EU approves Alexion’s Koselugo to treat adults with neurofibromatosis type 1 tumours
Approval based on pivotal KOMET Phase III trial demonstrating significant tumour reduction in adults with NF1
Approval based on pivotal KOMET Phase III trial demonstrating significant tumour reduction in adults with NF1
Basketball legend, entrepreneur, and entertainer Shaquille O’Neal partners with Lilly to encourage Americans to recognize the signs of obstructive sleep apnea and talk to their
The EIR was issued with an inspection classification of Voluntary Action Indicated (VAI) post the inspection conducted in June 2025
This approval marks a significant milestone in women’s health, introducing Bayer’s first hormone-free treatment for menopause-related symptoms
Medherant’s testosterone TEPI Patch could become the first-in-class testosterone patch developed specifically for women
The new CMC Process R&D Center represents a strategic investment in scale, sustainability, and specialization
It will produce a comprehensive range of dosage forms including tablets, hard gelatin capsules, liquids, injectables, topicals, and beta-lactam products
In the next five years, an additional 75,000 seats are expected to be added across both undergraduate and postgraduate levels
With milestone-linked funding of Rs. 5–25 crore per project (and up to Rs. 50 crore in exceptional cases), the Mission will support projects that bring impactful MedTech solutions to market
Bioconjugation capability to complement commercial payload, linker, and monoclonal antibody services
Subscribe To Our Newsletter & Stay Updated